New and newly updated publications from the Congressional Research Service that Congress has withheld from online public access include the following.
Egypt: Background and U.S. Relations, updated June 27, 2013
Mixed-Oxide Fuel Fabrication Plant and Plutonium Disposition: Management and Policy Issues, June 25, 2013
Ballistic Missile Defense in the Asia-Pacific Region: Cooperation and Opposition, June 24, 2013
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits, updated July 1, 2013
School Resource Officers: Law Enforcement Officers in Schools, June 26, 2013
President Obama’s Climate Action Plan, June 26, 2013
EPA Standards for Greenhouse Gas Emissions from Power Plants: Many Questions, Some Answers, June 26, 2013
Leaving Congress: House of Representatives and Senate Departures Data Since 1989, updated June 26, 2013
The Commodity Futures Trading Commission: Background and Current Issues, June 24, 2013
Tax Provisions Expiring in 2013 (“Tax Extenders”), updated June 27, 2013
Foreign Holdings of Federal Debt, updated June 24, 2013
Criminal Prohibitions on the Publication of Classified Defense Information, updated June 24, 2013
U.S. May Face Significant Obstacles in Attempt to Apprehend Edward Snowden, June 2013
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.